Quality Measures

The Samuel Oschin Comprehensive Cancer Institute aims to deliver the highest quality care to all our cancer patients. We constantly strive to follow the latest evidence-based guidelines that will result in the best outcomes for our patients. The patient satisfaction scores listed below show a significant percentage of our patients would recommend us to their family and friends as their provider of choice for cancer care.

SOCCI_QualityPageGraphics_586-1

To demonstrate our commitment to quality care, the cancer institute is accredited by the Commission on Cancer and participates in monitoring care associated with the quality-of-care guidelines for cancer care endorsed by the Commission on Cancer, the National Quality Forum, the American Society of Clinical Oncology and the National Comprehensive Cancer Network.

These quality-of-care guidelines include the following:

Breast

  • Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conservation surgery for breast cancer.
  • Tamoxifen or third-generation aromatase inhibitor is recommended or administered within 1 year (365 days) of diagnosis for women with T1cN0M0 or stage IB-III hormone receptor positive breast cancer.
  • Radiation therapy is recommended or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with ≥ 4 positive regional lymph nodes.
  • Image or palpation-guided needle biopsy to the primary site is performed to establish diagnosis of breast cancer.
  • Combination chemotherapy is recommended or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1cN0M0 or stage IB-III hormone receptor negative breast cancer.

Colorectal

  • At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.
  • Adjuvant chemotherapy is recommended or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer.
  • Preoperative chemo and radiation are administered for clinical AJCC T3N0, T4N0 or Stage III; or postoperative chemo and radiation are administered within 180 days of diagnosis for clinical AJCC T1-2N0 with pathologic AJCC T3N0, T4N0 or Stage III; or treatment is recommended; for patients under the age of 80 receiving resection for rectal cancer.

For diagnosis year 2014, Cedars-Sinai’s performance with evidence-based guidelines for cancer care for select cancer/tumor sites is presented below. (Data provided by the National Cancer Database.)

SOCCI_QualityPageGraphics_586-2
SOCCI_QualityPageGraphics_586-3
SOCCI_QualityPageGraphics_586-4
SOCCI_QualityPageGraphics_586-5
SOCCI_QualityPageGraphics_586-6
SOCCI_QualityPageGraphics_586-7
SOCCI_QualityPageGraphics_586-8
SOCCI_QualityPageGraphics_586-9